AMT vs STRO · P/E 31, rev $2.55B vs rev $62.0M
American Tower Corp (AMT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported AMT revenue for 2024-12-31 was $2.55B. Net income was $2.28B. Revenue was up 1.0% from 2024-09-30 to 2024-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the AMT and STRO stock pages for the full models.
Not investment advice.